NEULANDLAB.NS

Neuland Laboratories Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$18,072.00

-0.10%Jun 24, 2026

AI Brief

Market cap

$231.57B

52w range

—

P / E

—

EPS · FY 2026

$283.71

Volume

—

Revenue · FY 2026

$20.23B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Neuland Laboratories Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$18072.00

Change

+50.34%

Period high

$18113.00

Period low

$11555.00

Period start

$12021.002025-06-25

Through 2026-06-24

Fair value

Football field →

Weighted blend

$7,425.75

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

NEULANDLAB.NS

18,072+50.34%

H 19,747L 11,500MA50 16,429MA200 15,181Avg vol 66K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Real Estate
+1.26%
Utilities
+0.96%
Consumer Cyclical
+0.94%
Energy
+0.84%
Financial Services
+0.65%
Basic Materials
-0.11%
Communication Services
-0.40%
Healthcare
-0.41%
Industrials
-0.47%
Technology
-0.80%
Consumer Defensive
-1.00%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
+0.88%
Biotechnology
+6.56%
Financial - Mortgages
-4.05%
Home Improvement
+3.89%
Electrical Equipment & Parts
+3.88%
Paper, Lumber & Forest Products
+3.53%
Software - Services
-3.30%
Software - Infrastructure
-3.07%
Financial - Conglomerates
+2.62%
Auto - Dealerships
+2.54%
Luxury Goods
+2.47%
Auto - Recreational Vehicles
+2.22%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for NEULANDLAB.NS.

Peers

No peer list available for NEULANDLAB.NS.

Total assets

$29.3B

Total debt

$3.01B

Cash & equiv

$3.55B

Operating CF

$3.38B

Free cash flow

-$588.87M

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$20.23B	$4.83B	$3.64B	$283.71	+17.99%